Clinical Report: Genetic Mutation Analysis and Clinical Phenotypes in MMA
Overview
This study analyzes the clinical features and genetic mutations in 45 patients with neonatal-onset methylmalonic acidemia (MMA). Key findings include the prevalence of specific mutations and the common clinical manifestations that often lead to diagnostic delays.
Background
Methylmalonic acidemia (MMA) is the most prevalent organic acidemia in China and presents significant diagnostic challenges due to its non-specific symptoms. Early recognition and intervention are crucial to prevent severe complications and improve patient outcomes. Understanding the genetic and clinical characteristics of MMA can enhance clinician awareness and facilitate timely diagnosis.
Data Highlights
Characteristic
Combined MMA (n=32)
Isolated MMA (n=13)
Median Onset (days)
11
11
Feeding Difficulties
60.0%
60.0%
Failure to Thrive
57.8%
57.8%
Hyperammonemia
40.0%
40.0%
MMACHC Mutations
96.8%
0%
MMUT Mutations
0%
100%
Key Findings
Common clinical manifestations include feeding difficulties (60.0%) and failure to thrive (57.8%).
Combined MMA patients had significantly lower methionine and blood ammonia levels compared to isolated MMA patients.
Whole-exome sequencing revealed that 96.8% of combined MMA patients had MMACHC mutations.
Isolated MMA patients all had MMUT mutations, with c.729_730insTT being the most common.
Diagnostic delays are frequent due to non-specific early symptoms resembling other neonatal conditions.
Clinical Implications
Clinicians should maintain a high index of suspicion for MMA in neonates presenting with unexplained feeding difficulties, hyperammonemia, or seizures. Early screening for MMA through tandem mass spectrometry and urinary organic acid analysis is essential for timely diagnosis and management.
Conclusion
Neonatal-onset MMA presents with varied clinical phenotypes that can complicate diagnosis. Awareness of specific genetic mutations and clinical features can aid in early detection and improve patient outcomes.
